在海得拉巴,Bharat Bharat生物技术发射Nucelion 治疗器,这是一个新的CRDMO,提供细胞和基因疗法制造。 Bharat Biotech launches Nucelion Therapeutics in Hyderabad, a new CRDMO offering cell and gene therapy manufacturing.

Bharat生物科技于2025年11月3日在海得拉巴基因组谷地推出新的CRDMO Nucelion治疗技术, Bharat Biotech has launched Nucelion Therapeutics, a new CRDMO based in Hyderabad’s Genome Valley, on November 3, 2025. 符合全球监测方案要求的设施提供细胞和基因疗法的端到端服务,包括DNA样本、病毒和非病毒病媒,以及癌症、自体免疫紊乱和稀有遗传疾病的细胞疗法。 The GMP-compliant facility offers end-to-end services for cell and gene therapies, including plasmid DNA, viral and non-viral vectors, and cell therapies for cancers, autoimmune disorders, and rare genetic diseases. Nucelion以自己的领导独立运作,支持全球客户从早期发展到商业制造,并遵守林业发展局和EMA的标准。 Operating independently with its own leadership, Nucelion supports global clients from early development to commercial manufacturing, adhering to FDA and EMA standards. 该公司正在征聘有经验的专业人员,目的是在全世界扩大获得先进疗法的机会。 The company is recruiting experienced professionals and aims to expand access to advanced therapies worldwide.